Navigation Links
GeoVax Labs' CEO Update Letter to Shareholders
Date:1/9/2012

potential revenue value of such a product are in excess of $4 billion annually.

Preventative Vaccine Program

We are extremely fortunate to have the U.S. National Institutes of Health (NIH)-supported HIV Vaccine Trials Network (HVTN) continuing to conduct and fund our preventative vaccine trials. During 2011, several milestones were accomplished: (a) the publication of the results of our phase 1 clinical trial involving 120 participants, (b) the completion of enrollment of our phase 2a trial involving 300 participants and, (c) preparations for launching human clinical testing of the GM-CSF-adjuvanted form of our vaccine.

In the non-human primate model, the adjuvanted vaccine, which co-expresses GM-CSF in the DNA priming component, has shown outstanding and long lasting prevention (not just control) of infection. Because of its superior ability to prevent infection, our plan is to take the adjuvanted vaccine into efficacy trials launched as soon as late 2013.

Last month, it was announced that an application for FDA approval is being sought for a once-daily drug to reduce the risk of HIV infection among uninfected adults. While this made headlines and is a wonderful step toward the prevention of HIV infection, this is not a long-term practical solution to prevent infection. Medication and physician costs, side effects and patient compliance continue to be significant issues that such a drug regimen doesn't adequately address. Although you will read that individuals can achieve 73% protection if they faithfully take this drug, required strict adherence to the necessary prescribed drug therapy is rare. Once a vaccine is available, this method of prevention will no longer be an attractive option.  Similar to the market value for a therapeutic vaccine, current market estimates for a preventative vaccine exceed $4 billion annually.

An article in Nature published this month by researchers at Harvard Medical School
'/>"/>

SOURCE GeoVax Labs, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. GeoVax Labs First Patient Inoculated in Phase 1/2 Clinical Trial for HIV/AIDS Therapeutic Vaccine
2. GeoVax Phase 2a Clinical Trial Completes Enrollment
3. GeoVax $3.6 Million Award Increased to $4.4 Million by U.S. Government
4. GeoVax Labs, Inc. Announces Second Quarter Financial Results
5. GeoVax Labs HIV/AIDS Vaccine Development Leadership to be Highlighted During 2011 World Vaccine Congress
6. GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases
7. GeoVax Launches a Second Clinical Site to Test the Therapeutic Benefit of its HIV Vaccine
8. David A. Dodd Appointed Chairman of the Board of GeoVax Labs
9. GeoVax Announces Expansion of Phase 2a Human HIV/AIDS Vaccine Trial
10. GeoVax Awarded Federal Grant Under the Qualifying Therapeutic Discovery Project Program
11. GeoVax Labs Engages The Investor Relations Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Abaxis, Inc. (NasdaqGS: ... analysis systems, today reported financial results for the first ... quarter overview: , Revenues of $47.5 million, up ... EPS of $0.21, up 50% over last year,s comparable ... revenues of $7.2 million, up 20% over last year,s ...
(Date:7/24/2014)... 2014  IRIDEX Corporation (NASDAQ: IRIX ) ... 2014 financial results after the market closes on ... release, the Company will host a conference call with ... on Thursday, July 31, 2014 to ... developments. Interested parties may access the live ...
(Date:7/24/2014)... , July 24, 2014 Omnicell, Inc. ... of medication and supply management solutions and analytics ... Thursday, July 31, to discuss the Company,s Second ... Second Quarter 2014 earnings conference call and webcastWhen: ... , Randall Lipps, chairman, president and chief executive ...
Breaking Medicine Technology:Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11Omnicell to Release Second Quarter 2014 Earnings Results on July 31 2
... 2011 AccuVein LLC announced today that the United States ... for its vascular illumination technology and that a second patent ... additional patents pending in the United States and around the ... President and CEO of AccuVein. "Our technology team has built ...
... Delcath Systems, Inc. (NASDAQ: DCTH ) today ... Mark approval for its proprietary Hepatic CHEMOSAT™ Delivery System. ... the percutaneous intra-arterial administration of a chemotherapeutic agent (melphalan ... that a medical device complies with the Essential Requirements ...
Cached Medicine Technology:Award Winning Vascular Imaging Device Company Announces New Patents 2Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSATâ„¢ Delivery System 2Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSATâ„¢ Delivery System 3
(Date:7/24/2014)... Researchers at Le Bonheur Children,s Hospital and the ... a clinical trial of a new drug shown to ... healthy adult volunteers intranasally infected with respiratory syncytial virus ... respiratory tract infections in young children in the United ... the labs of Infectious Disease Specialist John DeVincenzo, MD. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 Memantine was initially ... first marketed in Germany under the brand name Akatinol; it ... nations as Ebixa and in the USA to Forest Labs ... 420 million in 2013. In the US, Forest reported Namenda ... protection expiry in Canada, Australia and the European region has ...
(Date:7/24/2014)... 24, 2014 As the age of ... egg freezing as a way to ensure future family ... decline with advancing reproductive age. Vitrification technology, a fast ... edge medical technology that allows a woman to have ... fertility years, which are then stored for future use. ...
(Date:7/24/2014)... scientists at Carnegie Mellon University, working with high-throughput ... Berkeley National Laboratory, have devised a computational method ... normal breast cells turn malignant and as they ... for analyzing how genes interact with each other ... published today by the online journal PLOS ...
(Date:7/24/2014)... In a recent report by CBS News, the ... end to criminal penalties associated with possession of small amounts ... reform in Washington DC, giving it one of the most ... penalties for possession of one ounce of marijuana or less ... more than an ounce of marijuana remain criminal offenses under ...
Breaking Medicine News(10 mins):Health News:RSV research breakthrough to help infected children 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3Health News:Washington D.C. Decriminalizes Marijuana 2
... Steven Reinberg HealthDay Reporter , THURSDAY, Nov. ... medications can help people with heart disease live ... according to new guidelines from the American College of ... Following the updated recommendations can also improve quality of ...
... have found important new relationships between obesity, sleep-disordered ... children. "The intricate interdependencies between BMI, ... of particular importance in children, as their brains ... Spruyt, PhD, assistant professor in the Department of ...
... Nancy Grace and her partner danced a lively rumba to Spandau ... more was going on in the legal commentator,s brain than worry ... millions of neurons were hard at work doing what they apparently ... MacManus,s movements to create a pas de deux that had the ...
... , THURSDAY, Nov. 3 (HealthDay News) -- Smokers are more ... area of their brain that processes emotions was damaged by ... people who planned to stop smoking before they had a ... than those who hadn,t thought about quitting. These findings ...
... has long been known that cancer cells use nutrients differently ... field of cancer metabolism has shed new light on the ... demonstrating that manipulation of an enzyme called PKM2 is important ... by a scientific team at Beth Israel Deaconess Medical Center ...
... to stay awake. Very bright light not only arouses us ... can make us sleepy. It,s the reason some people use ... sleep. Now researchers at UCLA have identified ... or not. Jerome Siegel, a professor of psychiatry at ...
Cached Medicine News:Health News:Rx for Heart Patients: Healthier Living, Medication 2Health News:Rx for Heart Patients: Healthier Living, Medication 3Health News:Body weight, sleep-disordered breathing and cognition linked in children 2Health News:It takes two: Brains come wired for cooperation, neuroscientist asserts 2Health News:Some Smokers More Likely to Quit After Stroke Than Others 2Health News:Study identifies an expanded role for PKM2 in helping cancer cells survive 2Health News:Study identifies an expanded role for PKM2 in helping cancer cells survive 3Health News:UCLA researchers identify brain cells responsible for keeping us awake 2
New!...
... Electrical I/A unit for planned ... aspiration (foot control). Independent irrigation, suction, ... allows the surgeon to control all ... all functions simultaneously. Preset and actual ...
... Anterior and Posterior segment surgeries Vitrectomy-Lensectomy ... Ventury or Peristaltic Linear Aspiration. Interchangeable ... specific cutting action. Easy to read ... Cutting speed-variable from 1- 600 cuts ...
...
Medicine Products: